Center for Biologics Evaluation and Research

Results: 1843



#Item
51Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Add to Reading List

Source URL: www.fda.gov

Language: English
52DEPARTMENT OF HEALTH AND HUMAN SERVICES  Public Health Service Food and Drug Administration Center for Biologics Evaluation and Research[removed]New Hampshire Ave

DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Center for Biologics Evaluation and Research[removed]New Hampshire Ave

Add to Reading List

Source URL: www.fda.gov

Language: English
53DEPARTMENT OF HEALTH & HUMAN SERVICES  Public Health Service Food and Drug Administration 1401 Rockville Pike

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike

Add to Reading List

Source URL: www.fda.gov

Language: English
54DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]CBER REGULATORY REVIEW MEMORANDUM Date

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]CBER REGULATORY REVIEW MEMORANDUM Date

Add to Reading List

Source URL: www.fda.gov

Language: English
55[removed]Federal Register / Vol. 80, No[removed]Tuesday, March 3, [removed]Notices TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN FOR BIOLOGICS 1—Continued[removed]b), Number of submissions to FDA of ‘‘supporting informati

[removed]Federal Register / Vol. 80, No[removed]Tuesday, March 3, [removed]Notices TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN FOR BIOLOGICS 1—Continued[removed]b), Number of submissions to FDA of ‘‘supporting informati

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-03-03 11:27:09
56Microsoft Word - 10970dft.doc

Microsoft Word - 10970dft.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
576728 ACTION: Federal Register / Vol. 80, No[removed]Friday, February 6, [removed]Notices Notice of meeting.

6728 ACTION: Federal Register / Vol. 80, No[removed]Friday, February 6, [removed]Notices Notice of meeting.

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-02-06 13:06:20
58Federal Register / Vol. 80, No[removed]Thursday, February 26, [removed]Notices title04/0403.htm. Karl Koerper, Reports Clearance Officer. [FR Doc. 2015–03924 Filed 2–25–15; 8:45 am] BILLING CODE 4184–73–P

Federal Register / Vol. 80, No[removed]Thursday, February 26, [removed]Notices title04/0403.htm. Karl Koerper, Reports Clearance Officer. [FR Doc. 2015–03924 Filed 2–25–15; 8:45 am] BILLING CODE 4184–73–P

Add to Reading List

Source URL: www.fda.gov

Language: English
59Microsoft Word - 16618dft.doc

Microsoft Word - 16618dft.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
60FDA’s Initiatives to Closing the Regulatory Science Knowledge Gap Leslie D. Wheelock, RN, MS Director, Office of Scientific Professional Development Office of the Chief Scientist

FDA’s Initiatives to Closing the Regulatory Science Knowledge Gap Leslie D. Wheelock, RN, MS Director, Office of Scientific Professional Development Office of the Chief Scientist

Add to Reading List

Source URL: www.fda.gov

Language: English